Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders

    September 2011 in “ American Journal of Clinical Dermatology ”
    María José Domínguez Vázquez, Ramón Navarra Amayuelas, Marta Lamarca … Maria D. Iniesta
    Studysummary This case series suggests that EE/CMA 0.03mg/2mg may help manage dermatological disorders related to androgen excess, as evidenced by symptomatic improvements in the four patients treated.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 18

    1. Effectiveness of Ethinylestradiol/Chlormadinone Acetate in Treating Dermatological Conditions Related to High Androgen Levels American Journal of Clinical Dermatology · 2011
    2. S1 Guideline for Diagnostic Evaluation in Androgenetic Alopecia in Men, Women, and Adolescents British Journal of Dermatology · 2010
    3. Efficacy of an Oral Contraceptive Containing EE 0.03 mg and CMA 2 mg (Belara) in Moderate Acne Resolution: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial Contraception · 2009
    4. The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report Fertility and Sterility · 2008
    5. Management of Androgenetic Alopecia in Postmenopausal Women Actas Dermo-Sifiliográficas · 2008
    6. A Review of Hormonal Therapy for Female Pattern (Androgenic) Alopecia Dermatology Online Journal · 2008
    7. Hirsutism New England journal of medicine/˜The œNew England journal of medicine · 2005
    8. Treatment of Female Pattern Hair Loss With Oral Antiandrogens British Journal of Dermatology · 2005
    9. Hirsutism and Acne in Polycystic Ovary Syndrome Baillière's best practice & research. Clinical obstetrics & gynaecology/Baillière's best practice and research in clinical obstetrics and gynaecology · 2004
    10. Androgenetic Alopecia in Women Journal of Investigative Dermatology Symposium Proceedings · 2003
    11. Finasteride for Female Androgenetic Alopecia British Journal of Dermatology · 2002
    12. Effects of Minoxidil 2% vs. Cyproterone Acetate Treatment on Female Androgenetic Alopecia: A Controlled, 12-Month Randomized Trial British Journal of Dermatology · 2002
    13. Acne American journal of clinical dermatology · 2002
    14. Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2001
    15. Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara®) and EE/LNG (Microgynon®) Dermatology · 2001
    16. Lack of Efficacy of Finasteride in Postmenopausal Women with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2000
    17. Measuring Reversal of Hair Miniaturization in Androgenetic Alopecia by Follicular Counts in Horizontal Sections of Serial Scalp Biopsies: Results of Finasteride 1mg Treatment of Men and Postmenopausal Women Journal of Investigative Dermatology Symposium Proceedings · 1999
    18. Androgenetic Alopecia in the Female: Treatment with 2% Topical Minoxidil Solution Archives of Dermatology · 1994

    Related research 1

    1. Medical Treatment Regimens of Hirsutism Reproductive biomedicine online · 2004